Click to watch — the full context on anticholinergic burden, the 2015 JAMA findings, and the three nutrition compounds researchers are now studying.
In 2015 a University of Washington team published a study in JAMA Internal Medicine that should have changed how America sleeps. They followed 3,434 adults for a full decade. The single strongest association with higher dementia risk was not a prescription drug. It was diphenhydramine — the exact ingredient in Benadryl, Advil PM, Tylenol PM, ZzzQuil and virtually every over-the-counter sleep aid sold in pharmacies.
Most people still have no idea. And the longer the cumulative exposure, the stronger the association became.
This is not about one night of poor sleep. It is about the quiet, nightly accumulation of a compound that interferes with the very neurotransmitter the brain uses to encode new memories — acetylcholine.
The latency is what makes this so dangerous. A single dose feels harmless. The research concern is years of nightly use — something millions of people do without ever discussing it with a doctor.
The same study that raised the red flag on diphenhydramine also opened a quiet conversation among researchers about compounds that support the cholinergic system from a completely different angle: pterostilbene (from blueberries), theobromine (from dark chocolate) and oleic acid (from avocado). The short video below walks through the data in plain language — no hype, no medical claims — just the published findings and practical context.
// peer-reviewed citations · no medical advice · physician-guided decisions only